Genetic characterization of vif, vpr, and vpu sequences from long-term survivors of human immunodeficiency virus type 1 infection

Virology

Volumn 228, Issue 2, 1997, Pages 340-349

  Zhang, Linqi ^a   Huang, Yaoxing ^a   Yuan, Hannah ^a   Tuttleton, Sarah ^a   Ho, David D ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; GENETIC VARIABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SURVIVAL;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0031575533     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.8378     Document Type: Article

References (55)

1. Bacchetti P., Moss A. R. Incubation period of AIDS in San Francisco. Nature. 338:1989;251-253.
2. Bour S., Schubert U., Strebel K. The human immunodeficiency virus type 1 vpu protein specifically binds to the cytoplasmic domain of CD4: Implications for the mechanism of degradation. J. Virol. 69:1995;1510-1520.
3. S. P. Buchbinder, D. Mann, L. Louie, F. Katz, S. D. Holmberg, 1993, Genetic cofactors for delayed HIV disease progression, IX International Conference on AIDS, Berlin, 46.
4. Cao Y., Qin L., Zhang L., Safrit J., Ho D. D. Virologic and immunologic characterization of long-term survivors of HIV-1 infection. N. Engl. J. Med. 332:1995;201-208.
5. Cohen E. A., Dehni G., Sodroski J. G., Haseltine W. A. Human immunodeficiency virus vpr product is a virion-associated regulatory protein. J. Virol. 64:1990;3097-3099.
6. Connor R., Sheridam K. E., Lai C., Zhang L., Ho D. D. Characterization of the functional properties of env genes from long-term survivors of human immunodeficiency virus type 1 infection. J. Virol. 70:1996;5306-5311.
7. Connor R. I., Chen B. K., Choe S., Landau N. R. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology. 206:1995;936-944.
8. Deacon N. J., Tsykin A., Solomon A., Smith K., Ludford-Menting M., Hooker D. J., McPhee D. A., Greenway A. L., Ellett A., Chatfield C., Lawson V. A., Crowe S., Maerz A., Sonza S., Learmont J., Sullivan J. S., Cunningham A., Dwyer D., Dowton D., Mills J. Genomic structure of an attenuated quasispecies of HIV-1 from a blood transfusion donor and recipients. Science. 270:1995;988-991.
9. di Marzio P., Choe S., Ebright M., Knoblauch R., Landau N. R. Mutagenic analysis of cell cycle arrest, nuclear localization, and virion packaging of HIV-1 Vpr. J. Virol. 69:1996;7909-7916.
10. Felsenstein J. Phylogenies from molecular sequences: Inference and reliability. Annu. Rev. Genet. 22:1988;521-565.
11. Goettlinger H. G., Dorfman T., Cohen E. A., Haseltine W. A. Vpu protein of human immunodeficiency virus type 1 enhances the release of capsids produced by gag gene constructs of widely divergent retroviruses. Proc. Natl. Acad. Sci. USA. 90:1993;7381-7385.
12. Goodnow M., Huet T., Saurin W., Kwok S., Sninsky J., Wain-Hobson S. HIV-1 isolates are rapidly evolving quasispecies: Evidence for viral mixtures and preferred nucleotide substitutions. J. Acquired Immunodefic. Syndr. 2:1989;344-352.
13. He J., Choe S., Walker R., Marzio P. D., Morgan D. O., Landau N. R. Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34 cdc2 activity. J. Virol. 69:1995;6705-6711.
14. Heinzinger N. K., Bukrinsky M. I., Haggerty S. A., Ragland A. M., Kewalramani V., Lee M., Gendelman H. E., Ratner L., Stevenson M., Emermann M. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc. Natl. Acad. Sci. USA. 91:1994;7311-7315.
15. Higgins D. G., Sharp P. M. Fast and sensitive multiple sequence alignments on a microcomputer. Comput. Appl. Biosci. 5:1989;151-153.
16. Huang Y. X., Zhang L., Ho D. D. Characterization of nef sequences in long-term survivors of human immunodeficiency virus type 1 infection. J. Virol. 69:1995a;93-100.
17. Huang Y. X., Zhang L., Ho D. D. Functional analysis of nef alleles derived from long-term survivors. J. Virol. 69:1995b;8142-8146.
18. Huet T. R., Cheynier A., Meyerhans A., Roelants G., Wain-Hobson S. Genetic organization of a chimpanzee lentivirus related to HIV-1. Nature (London). 345:1990;356-359.
19. Isaksson B., Albert J., Chiodi F., Furucrona A., Krook A., Putkonen P. AIDS two months after primary human immunodeficiency virus infection. J. Infect. Dis. 158:1988;866-868.
20. Iversen A. K. N., Shpaer E. G., Rodrigo A. G., Hirsch M. S., Walker B. D., Sheppard H. W., Merigan R. C., Mullins J. I. Persistence of attenuated rev genes in a human immunodeficiency virus type 1-infected asymptomatic individual. J. Virol. 69:1995;5743-5753.
21. Kaslow R. D., Duquesnoy R., Van Raden M., L. K., Marrari M., Friedman H., Su S., Saah A. J., Detels R., Phair J., Rinaldo C. A1, Cw7, B8, DR3 HLA antigen combination associated with rapid decline of T-helper lymphocytes in HIV-1 infection. Lancet. 335:1990;927-930.
22. Kimura M. A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J. Mol. Evol. 16:1988;111-120.
23. Kirchhoff F., Greenough T. C., Brettler D. B., Sullivan J. L., Desrosiers R. C. Absence of intact nef sequences in a long-term survivors with nonprogressive HIV-1 infection. N. Engl. J. Med. 332:1995;228-232.
24. Klimkait T., Strebel K., Hoggan M. D., Martin M., Orenstein J. M. The human immunodeficiency virus type 1-specific protein Vpu is required for efficient virus maturation and release. J. Virol. 64:1990;621-629.
25. N. R. Landau.
26. Learmont J., Tindall B., Evans L., Cunningham A., Cunningham P., Wells J., Penny R., Kaldor J., Cooper D. A. Long-term symptom-less HIV-1 infection in recipients of blood products from a single donor. Lancet. 340(340):1992;863-867.
27. Leigh Brown A. J. Sequence variability in human immunodeficiency viruses: Pattern and process in viral evolution. AIDS. suppl 2:1991;s35-s42.
28. Lenburg M. E., Landau N. R. Vpu-induced degradation of CD4: Requirement for specific amino acid residues in the cytoplasmic domain of CD4. J. Virol. 67:1993;7238-7245.
29. Levy D. N., Fernandes L. S., Williams W. V., Weiner D. B. Induction of cell differentiation by human immunodeficiency virus 1 vpr. Cell. 72:1993;541-550.
30. Levy J. A. HIV pathogenesis and long-term survival. AIDS. 7:1993;1401-1410.
31. Li W. H., Luo C. C. A new method for estimating synonymous and nonsynonymous rates of nucleotide substitution considering the relative likelihood of nucleotide and codon changes. Mol. Biol. Evol. 2:1985;150-174.
32. Lifson A. R., Buchbinder S. P., Sheppard H. W. Long-term human immunodeficiency virus infection in asymptomatic homosexual and bisexual men with normal CD4+ lymphocyte counts: Immunologic and virologic characteristics. J. Infect. Dis. 163:1991;959-965.
33. Liu R., Paxton W. A., Choe S., Ceradini D., Martin S. R., Horuk R., MacDonald M. E., Stuhlmann H., Koup R. A., Landau N. R. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell. 86:1996;367-377.
34. Ma X. Y., Sova P., Chao W., Volsky D. J. Cysteine residues in the Vif protein of human immunodeficiency virus type 1 are essential for viral infectivity. J. Virol. 68:1994;1714-1720.
35. Maniatis T., Fritsch E. F., Sambrook J. Molecular Cloning: A Laboratory Manual. 1982;Cold Spring Harbor University Press, Cold Spring Harbor.
36. McLean K. A., Holmes D. A., Evans B. A. Rapid clinical and laboratory progression of HIV infection. AIDS. 4:1990;369-371.
37. McNeary T., Hornickova Z., Markham R., Birdwell A., Arens M., Saah A., Ratner L. Relationship of human immunodeficiency virus type 1 sequence heterogeneity to stage disease. Proc. Nat. Acad. Sci. USA. 89:1992;10247-10251.
38. Mellors J. W., Rinaldo C. R., Gupta P., White R. M., Todd J. A., Kingsley L. A. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science. 272:1996;1167-1170.
39. Michael N. L., Chang G., D'arcy L. A., Ehrenberg P. K., Mariani R., Busch M. P., Birx D. L., Schwartz D. H. Defective accessory genes in a human immunodeficiency virus type 1-infected long-term survivors lacking recoverable virus. J. Virol. 69:1995;4228-4236.
40. Nei M., Gojobori T. Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol. Biol. Evol. 3:1986;418-426.
41. O'Brien T., Blattner W. A., Waters D., Eyster E., Hilgartner M. W., Cohen A. R., Luban N., Hatzakis A., Aledort L. M., Rosenberg P. S., Miley W. J., Kroner B. L., Goedert J. J. Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study. J. Am. Med. Assoc. 276:1996;105-110.
42. Oberste M. S., Gonda M. A. Conservation of amino-acid sequence motifs in lentivirus vif proteins. Virus Genes. 6:1992;95-102.
43. Paxton W., Connor R. I., Landau N. R. Incorporation of Vpr into human immunodeficiency virus type-1 virions: Requirement for the p6 regions of gag and mutational analysis. J. Virol. 67:1993;7229-7237.
44. Rinaldo C., Huang X., Fan Z., Ding M., Beltz L., Logar A., Panical D., Mazzara G., Liebmann J., Cottrill M., Gupta P. High level of anti-human immunodeficiency virus type 1 memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors. J. Virol. 69:1995;5838-5842.
45. Rogel M. E., Wu L. I., Emermann M. The human immunodeficiency virus type vpr gene prevents cell proliferation during chronic infection. J. Virol. 69:1995;882-888.
46. Sakai K., Ma X. Y., Gordienko I., Volsky D. J. Recombinational analysis of a natural noncytopathic human immunodeficiency virus type 1 (HIV-1) isolate: Role of the vif gene in HIV-1 infection kinetics and cytopathicity. J. Virol. 65:1991;5765-5773.
47. Samson M., Libert F., Doranz B. J., Rucker J., Liesnard C., Farber C., Saragosti S., Lapoumeroulie C., Cognaux J., Forceille C., Muydermans G., Verhofstede C., Burtonboy G., Georges M., Imai T., Rana S., Yi R., Smyth R. J., Vassart G., Parmentier M. Resistance of HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature. 382:1996;722-725.
48. Schrager L. K., Young J. M., Fowler M. G., Mathieson B. J., Vermund S. H. Long-term survivors of HIV-1 infection: Definitions and research challenges. AIDS. 8(suppl 1):1994;s95-s108.
49. Schubert U., Bour S., Ferrer-Montiel A. V., Nontal M., Maldarelli F., Strebel K. The two biological activities of human immunodeficiency virus type 1 Vpu protein involve two separable structural domains. J. Virol. 70:1996;809-819.
50. Schubert U., Strebel K. Differential activities of the human immunodeficiency virus type 1-encoded vpu protein are regulated by phosphorylation and occur in different cellular compartment. J. Virol. 68:1994;2260-2271.
51. Sova A., Ranst M., Gupta P., Balachandran R., Chao W., Itescu S., Mckinley G., Volsky D. J. Conservation of an intact human immunodeficiency virus type 1 vif gene in vitro and in vivo. J. Virol. 69:1995;2557-2564.
52. Trono D. HIV accessory proteins: Leading roles for the supporting cast. Cell. 82:1995;189-192.
53. von Schwedler U., Song J., Aiken C., Trono D. vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells. J. Virol. 67:1993;4945-4955.
54. Wieland U., Hartmann J., Suhr H., Zalzberger B., Eggers H. J., Kuhn J. E. In vivo genetic variability of the HIV-1 vif gene. Virology. 203:1994;43-51.
55. Williams L. M., Cloyd M. W. Polymorphic human gene(s) determines differential susceptibility of CD4 lymphocytes to infection by certain HIV-1 isolates. Virology. 184:1991;723-728.